1
/
of
1
Paloset (Palonosetron)
Paloset (Palonosetron)
Regular price
₱3,600.00 PHP
Regular price
Sale price
₱3,600.00 PHP
Taxes included.
Quantity
Couldn't load pickup availability
Paloset (Palonosetron) is a prescription antiemetic medication belonging to the class of selective serotonin 5-HT3 receptor antagonists. This second-generation antiemetic agent is specifically formulated to prevent nausea and vomiting associated with chemotherapy and postoperative procedures. Palonosetron works by blocking serotonin receptors in the body that trigger nausea and vomiting responses, offering superior efficacy compared to first-generation 5-HT3 antagonists due to its extended half-life and enhanced receptor binding affinity.
Palonosetron is clinically indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV), particularly in patients receiving moderately to highly emetogenic chemotherapy regimens. It is also effective in preventing postoperative nausea and vomiting (PONV) following anesthesia and surgical procedures. The medication's prolonged duration of action makes it especially valuable for managing delayed emesis that occurs beyond 24 hours after chemotherapy administration.
As a prescription medication, Palonosetron should only be used under direct medical supervision and according to physician dosage instructions. Patients with known hypersensitivity to palonosetron or other 5-HT3 antagonists should avoid this medication. Caution is advised in patients with electrolyte imbalances, pre-existing cardiac arrhythmias, or those concurrently taking QT-prolonging drugs, as palonosetron may increase the risk of QT interval prolongation. Always consult with your healthcare provider before starting treatment to ensure appropriate dosing and to discuss potential drug interactions or contraindications based on your individual medical history.
Palonosetron is clinically indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV), particularly in patients receiving moderately to highly emetogenic chemotherapy regimens. It is also effective in preventing postoperative nausea and vomiting (PONV) following anesthesia and surgical procedures. The medication's prolonged duration of action makes it especially valuable for managing delayed emesis that occurs beyond 24 hours after chemotherapy administration.
As a prescription medication, Palonosetron should only be used under direct medical supervision and according to physician dosage instructions. Patients with known hypersensitivity to palonosetron or other 5-HT3 antagonists should avoid this medication. Caution is advised in patients with electrolyte imbalances, pre-existing cardiac arrhythmias, or those concurrently taking QT-prolonging drugs, as palonosetron may increase the risk of QT interval prolongation. Always consult with your healthcare provider before starting treatment to ensure appropriate dosing and to discuss potential drug interactions or contraindications based on your individual medical history.
Share
